Stimulation of cystic fibrosis transmembrane conductance regulator-dependent short-circuit currents across ΔF508 murine intestines

被引:16
|
作者
Steagall, WK
Drumm, ML
机构
[1] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA
关键词
D O I
10.1016/S0016-5085(99)70502-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The cystic fibrosis transmembrane conductance regulator (CFTR) can be activated by pharmacological manipulation of the protein kinase A pathway in cell lines. Our goals were to stimulate wild-type CFTR in murine intestines via isoform-specific phosphodiesterase inhibition or protein kinase A activation and to apply the optimal stimulus to activate chloride secretion from homozygous Delta F508 jejunum, Methods: The response of T84 cells and sections of murine intestine to various inhibitors and activators was examined by Ussing chamber experiments. Results: Maximal chloride secretion can be activated in T84 cells with application of class III phosphodiesterase inhibitors and in wild-type murine intestines with class I or III phosphodiesterase inhibitors or with activators of type II protein kinase A. Chloride secretion can be stimulated from homozygous Delta F508 murine jejunum using a mixture of inhibitors and activators. Conclusions: Delta F508 CFTR can be activated to levels 4% of wild-type when the combination of protein kinase A type II activators and phosphodiesterase class I and III inhibitors are used in murine jejunum, This result suggests that partial CFTR-mediated electrolyte transport can be restored in Delta F508 murine jejunum by application of specific pharmacological agents.
引用
收藏
页码:1379 / 1388
页数:10
相关论文
共 50 条
  • [31] Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients
    Dray-Charier, N
    Paul, A
    Scoazec, JY
    Veissière, D
    Mergey, M
    Capeau, J
    Soubrane, O
    Housset, C
    HEPATOLOGY, 1999, 29 (06) : 1624 - 1634
  • [32] Post-translational disruption of the ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes ΔF508 CFTR in the rabbit reticulocyte lysate
    Fuller, W
    Cuthbert, AW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) : 37462 - 37468
  • [33] Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression
    Steagall, WK
    Elmer, HL
    Brady, KG
    Kelley, TJ
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 22 (01) : 45 - 50
  • [34] Increased Mortality in Cystic Fibrosis Transmembrane Conductance Receptor Delta F508 Carriers With Heart Failure
    Salman, Ali
    Borcherding, Jennifer
    Schultz, Allyson
    Comellas, Alejandro
    Johnson, Frances
    CIRCULATION, 2011, 124 (21)
  • [35] A Delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo
    French, PJ
    vanDoorninck, JH
    Peters, RHPC
    Verbeek, E
    Ameen, NA
    Marino, CR
    deJonge, HR
    Bijman, J
    Scholte, BJ
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06): : 1304 - 1312
  • [36] Interleukin 8 secretion from monocytes of subjects heterozygous or the ΔF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered
    Zaman, MM
    Gelrud, A
    Junaidi, O
    Regan, MM
    Warny, M
    Shea, JC
    Kelly, C
    O'Sullivan, BP
    Freedman, SD
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (05) : 819 - 824
  • [37] Dynasore inhibits removal of wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane
    Young, Andrew
    Gentzsch, Martina
    Abban, Cynthia Y.
    Jia, Ying
    Meneses, Patricio I.
    Bridges, Robert J.
    Bradbury, Neil A.
    BIOCHEMICAL JOURNAL, 2009, 421 : 377 - 385
  • [38] Structure-Activity Relationships of Cyanoquinolines with Corrector-Potentiator Activity in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Protein
    Knapp, John M.
    Wood, Alex B.
    Puay-Wah Phuan
    Lodewyk, Michael W.
    Tantillo, Dean J.
    Verkman, A. S.
    Kurth, Mark J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) : 1242 - 1251
  • [39] The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice
    Fontes, Ghislaine
    Ghislain, Julien
    Benterki, Isma
    Zarrouki, Bader
    Trudel, Dominique
    Berthiaume, Yves
    Poitout, Vincent
    DIABETES, 2015, 64 (12) : 4112 - 4122
  • [40] Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and ΔF508 processing
    Cebotaru, Liudmila
    Vij, Neeraj
    Ciobanu, Igor
    Wright, Jerry
    Flotte, Terence
    Guggino, William B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (32) : 21926 - 21933